Physician profile
Allison P Wall
NPI 1346446671
$23,783.68
in general payments reported to CMS, 2019-2025
85 companies · $5,673 in 2025
The $5,673 reported for 2025 was more than what 83% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,696 · 2020: $2,206 · 2021: $2,605 · 2022: $3,512 · 2023: $4,038 · 2024: $4,055 · 2025: $5,673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,547.56 |
| Education | $217.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,071.23 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,539.88 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $1,257.77 | 2019-2025 | Erleada, Akeega, Darzalex |
| Eisai INC. | $1,251.48 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,246.33 | 2019-2025 | Lynparza, Calquence, Imfinzi |
| Pfizer INC. | $943.45 | 2019-2025 | |
| Amgen INC. | $843.06 | 2019-2023 | Kyprolis, Xgeva, Nplate |
| Genentech USA, INC. | $841.94 | 2019-2025 | Polivy, Phesgo, Tecentriq |
| Exelixis INC. | $838.74 | 2020-2025 | Cabometyx |
| Daiichi Sankyo INC. | $817.49 | 2019-2025 | Enhertu, Datroway, Injectafer |
| Lilly USA, LLC | $802.49 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| E.R. Squibb & Sons, L.L.C. | $779.84 | 2019-2025 | Opdivo, Reblozyl |
| Celgene Corporation | $727.91 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Genzyme Corporation | $601.40 | 2019-2025 | |
| Glaxosmithkline, LLC. | $570.62 | 2020-2025 | Jemperli, Zejula, Ojjaara |
Show all 85 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $554.45 | 2020-2025 | Jakafi, Monjuvi, Niktimvo |
| Gilead Sciences, INC. | $485.21 | 2021-2025 | Trodelvy |
| Puma Biotechnology, INC. | $461.95 | 2019-2025 | Nerlynx |
| Astellas Pharma US INC | $393.66 | 2019-2025 | Xtandi, Vyloy, Padcev |
| Bayer Healthcare Pharmaceuticals INC. | $370.04 | 2019-2025 | |
| Tersera Therapeutics LLC | $350.36 | 2023-2025 | Zoladex, Xermelo |
| Ipsen Biopharmaceuticals, INC | $337.90 | 2019-2025 | Onivyde, Somatuline Depot |
| Pharmaessentia USA Corporation | $289.44 | 2023-2025 | Besremi |
| Karyopharm Therapeutics INC. | $289.43 | 2020-2025 | Xpovio |
| Array Biopharma INC | $288.04 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Pharmacyclics LLC, An Abbvie Company | $273.33 | 2020-2023 | Imbruvica |
| Beigene USA, INC. | $243.03 | 2020-2025 | Brukinsa |
| Takeda Pharmaceuticals U.S.A., INC. | $219.29 | 2019-2025 | Fruzaqla, Ninlaro |
| Adaptive Biotechnologies Corporation | $217.20 | 2023-2025 | Clonoseq |
| Sanofi-Aventis U.S. LLC | $208.74 | 2020-2023 | |
| Stemline Therapeutics INC. | $187.97 | 2023-2025 | Orserdu |
| Pharmacosmos Therapeutics INC. | $185.12 | 2021-2025 | Monoferric, Cosela |
| Regeneron Healthcare Solutions, INC. | $183.91 | 2021-2025 | Libtayo, Lynozyfic |
| Taiho Oncology, INC. | $161.69 | 2020-2025 | |
| Coherus Oncology, INC. | $154.04 | 2020-2023 | |
| Emmaus Medical, INC. | $151.86 | 2020-2022 | |
| Sobi, INC | $151.43 | 2023-2025 | |
| Seagen INC. | $134.30 | 2020-2023 | Tukysa |
| Emd Serono, INC. | $121.97 | 2020-2025 | Bavencio |
| Rigel Pharmaceuticals, INC. | $117.71 | 2020-2025 | Rezlidhia, Gavreto, Tavalisse |
| Abbvie INC. | $117.33 | 2020-2025 | Venclexta |
| Genmab U.S., INC. | $117.27 | 2023-2025 | Tivdak, Epkinly |
| Alexion Pharmaceuticals, INC. | $115.82 | 2022-2025 | Ultomiris |
| Teva Pharmaceuticals USA, INC. | $102.92 | 2019-2020 | |
| Aveo Pharmaceuticals, INC. | $95.73 | 2023-2025 | Fotivda |
| Jazz Pharmaceuticals INC. | $93.97 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $89.45 | 2019-2022 | |
| Apellis Pharmaceuticals, INC. | $88.61 | 2023-2025 | Empaveli |
| Beone Medicines USA, INC. | $77.54 | 2025 | Brukinsa, Tevimbra |
| Kite Pharma, INC. | $67.66 | 2021-2022 | |
| Caris Mpi, INC. | $67.08 | 2025 | Mi Cancer Seek |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.11 | 2021-2025 | |
| Foundation Medicine, INC. | $56.99 | 2019-2022 | |
| Clovis Oncology, INC. | $54.41 | 2019-2020 | |
| Sanofi US Services INC. | $54.04 | 2025 | |
| Acceleron Pharma, INC. | $49.51 | 2021 | |
| Morphosys, US INC. | $49.23 | 2021-2023 | Monjuvi |
| Geron Corporation | $45.53 | 2025 | Rytelo |
| Servier Pharmaceuticals LLC | $44.27 | 2024-2025 | |
| G1 Therapeutics, INC. | $42.52 | 2022-2023 | Cosela |
| Mirati Therapeutics, INC. | $40.63 | 2023-2024 | Krazati |
| Azurity Pharmaceuticals, INC. | $36.05 | 2025 | Danziten |
| Kyowa Kirin, INC. | $35.72 | 2021-2023 | Poteligeo |
| Lexicon Pharmaceuticals, INC. | $35.43 | 2019-2020 | |
| Adc Therapeutics America, INC. | $34.52 | 2022 | |
| Veracyte, INC. | $33.83 | 2024 | |
| Deciphera Pharmaceuticals INC. | $33.12 | 2021-2024 | Qinlock |
| Dova Pharmaceuticals | $28.87 | 2021 | |
| Boston Scientific Corporation | $28.72 | 2021 | |
| Springworks Therapeutics, INC. | $28.44 | 2024 | Ogsiveo |
| Syndax Pharmaceuticals, INC. | $27.74 | 2025 | |
| Tesaro, INC. | $26.40 | 2019 | |
| Tactile Systems Technology INC | $25.12 | 2021 | |
| Blueprint Medicines Corporation | $24.95 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $23.71 | 2024 | |
| Alnylam Pharmaceuticals INC. | $21.26 | 2024 | Givlaari |
| Immunocore Limited | $18.46 | 2025 | Kimmtrak |
| Sumitomo Pharma America, INC. | $17.98 | 2025 | Orgovyx |
| Verastem, INC. | $17.57 | 2019 | |
| Tempus Ai, INC | $15.64 | 2024 | |
| Cti Biopharma Corp. | $15.31 | 2023 | Vonjo |
| Invivyd INC | $15.05 | 2025 | Pemgarda |
| Immunomedics, INC. | $14.86 | 2020 | |
| Dendreon Pharmaceuticals LLC | $14.14 | 2025 | Provenge |
| Idorsia Pharmaceuticals US INC | $13.47 | 2023 | Quviviq |
Drugs and devices associated with these payments
Keytruda $842Lenvima $771Opdivo $532Reblozyl $485Lynparza $481Jaypirca $471Verzenio $450Cabometyx $443Enhertu $435Kisqali $388Trodelvy $299Besremi $289Xtandi $285Tukysa $242Erleada $238Ibrance $220Jemperli $218Zejula $218Clonoseq $217Welireg $213Scemblix $213Fabhalta $212Zoladex $205Calquence $202Braftovi $199Orserdu $188Sarclisa $177Ojjaara $176Imfinzi $174Brukinsa $173Jakafi $171Akeega $163Mektovi $163Darzalex $159Imbruvica $155Talvey $154Retevmo $154Lorbrena $153Tecvayli $149Jevtana $148Xermelo $145Balversa $138Pluvicto $132Doptelet $125Padcev $121Monjuvi $121Lonsurf $117Inqovi $117Orgovyx $116Talzenna $112Pomalyst $112Nubeqa $112Polivy $111Rybrevant $107Fruzaqla $102Tivdak $99.10Datroway $98.59Xalkori $97.34Ultomiris $96.78Inlyta $96.05Fotivda $95.73Xofigo $92.49Tavalisse $90.80Rezlidhia $90.80Onivyde $88.74Empaveli $88.61Monoferric $88.07Cosela $86.03Promacta $84.24Piqray $81.08Libtayo $77.53Elrexfio $77.37Nerlynx $77.36Tasigna $76.19Xpovio $73.98Phesgo $69.97Tecentriq $68.99Mi Cancer Seek $67.08Mekinist $63.38Vyloy $62.64Lunsumio $61.53Opdualag $60.90Venclexta $60.86Injectafer $60.62Zepzelca $59.51Adcetris $59.37Kyprolis $58.15Gavreto $53.69Paxlovid $53.36Ninlaro $52.63Bosulif $47.45Comirnaty $46.19Rytelo $45.53Tibsovo $44.27Somatuline Depot $43.01Epkinly $42.97Columvi $42.38Vectibix $41.83Xgeva $41.83Nplate $41.83
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Wall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.